PTCT icon

PTC Therapeutics
PTCT

Overview Fund Activity

174 hedge funds and large institutions have $2.21B invested in PTC Therapeutics in 2019 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 77 increasing their positions, 36 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
174
Holders Change
+10
Holders Change %
+6.1%
% of All Funds
3.77%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.15%
New
32
Increased
77
Reduced
36
Closed
22
Calls
$10M
Puts
$8.99M
Net Calls
+$1.05M
Net Calls Change
+$4.94M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$54.2M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$53.4M
3
PHS
PFM Health Sciences
California
+$40.9M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$29.1M
5
RI
RTW Investments
New York
+$22.3M

Top Sellers

1
BC
Boxer Capital
California
-$43.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$13.8M
3
ACA
Avoro Capital Advisors
New York
-$13M
4
PP
PDT Partners
New York
-$9.53M
5
SFM
Sphera Funds Management
Israel
-$4.71M
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
$20.3M +$14.1M +374,690 +229%
ECP
27
Elk Creek Partners
Colorado
$17.6M +$3.38M +89,863 +24%
SAM
28
Sectoral Asset Management
Quebec, Canada
$17.4M +$8.64M +229,601 +98%
CS
29
Candriam SCA
Luxembourg
$17.4M +$2.26M +60,000 +15%
AC
30
Armistice Capital
New York
$15.1M +$3.76M +100,000 +33%
PAMU
31
Pictet Asset Management (UK)
United Kingdom
$14.9M +$4.11M +109,206 +38%
FCM
32
Frontier Capital Management
Massachusetts
$13.9M +$7.19M +191,004 +107%
BNP Paribas Asset Management
33
BNP Paribas Asset Management
France
$13.8M +$4.56M +121,257 +50%
Charles Schwab
34
Charles Schwab
California
$13.5M +$1.45M +38,487 +12%
UBS AM
35
UBS AM
Illinois
$11.6M +$1.19M +31,489 +11%
TA
36
Teachers Advisors
New York
$11.4M +$346K +9,202 +3%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$11.4M +$1.64M +43,700 +17%
EA
38
Emerald Advisers
Pennsylvania
$11.3M +$2.93M +77,928 +35%
AI
39
Atom Investors
Texas
$11.2M +$3.76M +99,952 +50%
Citigroup
40
Citigroup
New York
$10.7M +$3.91M +103,870 +58%
Bank of America
41
Bank of America
North Carolina
$10.4M +$3.37M +89,613 +48%
EMFAT
42
Emerald Mutual Fund Advisers Trust
Pennsylvania
$10.3M +$2.54M +67,359 +32%
Invesco
43
Invesco
Georgia
$9.49M +$1.26M +33,393 +15%
AQR Capital Management
44
AQR Capital Management
Connecticut
$9.13M -$385K -10,232 -4%
IBT
45
International Biotechnology Trust
United Kingdom
$9.05M +$9.05M +240,493 New
Prudential Financial
46
Prudential Financial
New Jersey
$8.94M +$8.94M +237,611 New
DM
47
Deerfield Management
New York
$8.92M +$8.92M +237,000 New
SFM
48
Sphera Funds Management
Israel
$8.3M -$4.71M -125,000 -36%
TCIM
49
TIAA CREF Investment Management
New York
$8.2M +$219K +5,819 +3%
OM
50
Opaleye Management
Massachusetts
$8.05M +$896K +23,800 +13%
1
2
3 4 5